We are live on ! Find out more
VP

Vitruvian Partners Portfolio holdings

AUM $112M
1-Year Est. Return 2.02%
This Fund
S&P 500
This Quarter Est. Return
-18.26%
1 Year Est. Return
+2.02%
3 Year Est. Return
+35.84%
5 Year Est. Return
+18.92%
10 Year Est. Return
AUM
$112M
AUM Growth
-$27.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 47.8%
2 Technology 25%
3 Consumer Discretionary 20.2%
4 Industrials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNGE
1
Hinge Health
HNGE
$6.74B
$48.2M 43.09%
1,250,000
MQ icon
2
Marqeta
MQ
$1.84B
$28M 25%
1,713,296
CARG icon
3
CarGurus
CARG
$3.16B
$16.1M 14.4%
472,959
XMTR icon
4
Xometry
XMTR
$5.44B
$7.84M 7.01%
191,919
GLBE icon
5
Global E Online
GLBE
$6.4B
$6.48M 5.8%
210,209
MXCT icon
6
MaxCyte
MXCT
$133M
$3.54M 3.17%
5,043,356
RXST icon
7
RxSight
RXST
$230M
$1.72M 1.54%
278,865

Similar funds

Vitruvian Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Vitruvian Partners held 7 positions worth $112M, down 20% from $139M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 0%. Vitruvian Partners opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 49% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Vitruvian Partners's ten largest holdings make up 100% of its $112M portfolio in Q1 2026.
  • Vitruvian Partners opened 0 new positions and closed 0 in Q1 2026.
  • Vitruvian Partners's portfolio value fell 20% quarter-over-quarter to $112M.

Based on Vitruvian Partners's 13F filing for Q1 2026, filed 11 May 2026.